SAN FRANCISCO -- More adults with moderate-to-severe Crohn's disease (CD) reached clinical remission after 6 months on ...

AbbVie said on Friday that the U.S. Food and Drug Administration approved its drug for complicated intra-abdominal infections ...

The pharmaceutical giant named Jeffrey Legos the head of a division it is counting on to overcome investor pressure and grow ...

Invest in essential sectors like consumer staples and energy to beat inflation. See why these stocks offer reliable dividends ...

Welcome to the Wall Street Week newsletter, bringing you stories of capitalism about things you need to know, but even more ...

There are some new tools to help this respiratory virus season: over-the-counter tests that can identify whether an illness ...

Sir Keir Starmer is driving the UK into “irrelevance”, the boss of one of Britain’s fastest-growing healthcare companies has ...

The recent FDA approvals of two treatments for molluscum contagiosum may represent a shift in how clinicians view this disease, according to a speaker at Masters of Pediatric Dermatology.In an ...

As the U.S. continues to wait for newer sunscreen ingredients, patients should use tinted sunscreens to protect against visible light that causes photodamage, melasma and hyperpigmentation, according ...

Q4 2024 Earnings Call Transcript February 7, 2025 Iterum Therapeutics plc beats earnings expectations. Reported EPS is $-0.12, expectations were $-0.24. Operator: Hello, everyone. And welcome to the ...

We in Chautauqua County know all about grapes and wine, and for more than 150 years we supplied the world. But now we have a new product from individuals in CHQ who have perfected the art of Making ...

Iterum Therapeutics (($ITRM)) has held its Q4 earnings call. Read on for the main highlights of the call. During Iterum Therapeutics’ latest ...